Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics. Academic Article uri icon

Overview

abstract

  • We conducted high-dimensional propensity score-adjusted cohort studies to examine whether thiazolidinedione use with a statin or fibrate was associated with an increased risk of severe hypoglycemia. We found that concomitant therapy with a thiazolidinedione+fibrate was associated with a generally delayed increased risk of severe hypoglycemia.

publication date

  • March 14, 2016

Research

keywords

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemia
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Thiazolidinediones

Identity

PubMed Central ID

  • PMC4890073

Scopus Document Identifier

  • 84962269907

Digital Object Identifier (DOI)

  • 10.1016/j.diabres.2016.03.006

PubMed ID

  • 27242124

Additional Document Info

volume

  • 115